Literature DB >> 11022134

SDF-1-induced activation of ERK enhances HIV-1 expression.

M Montes1, N E Tagieva, N Heveker, C Nahmias, F Baleux, A Trautmann.   

Abstract

Chemokine receptors are not only able to bind chemokines but, together with CD4, they serve as an entry door for the human immunodeficiency virus type 1 (HIV-1). The signalling capacity of chemokine receptors, which is of fundamental importance for chemokine-induced chemotaxis, is not used by HIV-1 to enter a target cell, nor by chemokines or chemokine-derived ligands to inhibit viral entry. In addition, an ill-defined signal triggered by chemokines can, under some circumstances, lead to an increase in HIV-1 expression. We show here that, in infected cells, exposure to SDF-1 leads to an increased expression of a X4 strain of HIV-1. A similar increase can be induced by an N-terminal peptide of SDF-1 which had previously been shown to elicit an intracellular calcium response and to inhibit the entry of X4 strains of HIV-1. We demonstrate the involvement of extracellular signal-regulated kinases (ERK) in this phenomenon. SDF-1 activates ERK-1 and ERK-2 in Jurkat cells. In HeLa cells, ERK-2 only is activated by SDF-1 or by a SDF-derived peptide. This ERK activation can be blocked by pertussis toxin and by the MEK inhibitor U0126. Most importantly, SDF-1-dependent HIV-1 expression is abolished by pretreating the cells with pertussis toxin or with U0126. The consequences of this SDF-1-induced, ERK-dependent modulation of HIV-1 expression in infected cells may have a clinical relevance for eradicating latent viruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022134

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  5 in total

1.  Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages.

Authors:  Shuzhen Chen; Daniel L Tuttle; Joseph T Oshier; Harm J Knot; Wolfgang J Streit; Maureen M Goodenow; Jeffrey K Harrison
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

2.  The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity.

Authors:  Carisa A Zampieri; Jean-Francois Fortin; Garry P Nolan; Gary J Nabel
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

3.  Natural Killer cell-dependent and non-dependent anti-viral activity of 2-Cys Peroxiredoxin against HIV.

Authors:  Mohammed Asmal; Norman L Letvin; Ralf Geiben-Lynn
Journal:  Int Trends Immun       Date:  2013-10

4.  Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction.

Authors:  David J Grainger; Andrew M L Lever
Journal:  Retrovirology       Date:  2005-04-04       Impact factor: 4.602

5.  An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.

Authors:  Raymond W Wong; Ahalya Balachandran; Peter K Cheung; Ran Cheng; Qun Pan; Peter Stoilov; P Richard Harrigan; Benjamin J Blencowe; Donald R Branch; Alan Cochrane
Journal:  PLoS Pathog       Date:  2020-02-18       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.